May 1, 2017 09:50 AM EDTUpdated 10:12 AM

Robert Plenge tapped to run immunology R&D at Celgene; Tesaro files LAG-3 IND

Shehla Shakoor

Managing Director

→ Robert Plenge is taking the plunge at Celgene. The ex-Merck investigator is moving out of Big Pharma to take charge of immunology research for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Robert Plenge tapped to run immunology R&D at Celgene; Tesaro files LAG-3 IND

Shehla Shakoor

Managing Director

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

GSK awaits Nucala decision after FDA target date passes

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis

AstraZeneca loses appeals court fight over IRA drug price negotiations

AI-focused biotech insitro cuts 22% of staff, citing 'tumultuous market'

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

Robert Plenge tapped to run im­munol­o­gy R&D at Cel­gene; Tesaro files LAG-3 IND

Managing Director

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Robert Plenge tapped to run immunology R&D at Celgene; Tesaro files LAG-3 IND